UBS Group AG - DIFFUSION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$13,000
+333.3%
31,096
+417.1%
0.00%
Q2 2018$3,000
-81.2%
6,014
-78.9%
0.00%
Q1 2018$16,000
+77.8%
28,496
+255.9%
0.00%
Q4 2017$9,000
+125.0%
8,006
+236.1%
0.00%
Q3 2017$4,000
-66.7%
2,382
-53.2%
0.00%
Q2 2017$12,000
+140.0%
5,091
+293.1%
0.00%
Q1 2017$5,000
+400.0%
1,295
+184.0%
0.00%
Q4 2016$1,0004560.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Swift Run Capital 2,508,017$1,369,0000.98%
WHITTIER TRUST CO OF NEVADA INC 135,551$73,0000.01%
Virtu Financial LLC 25,335$14,0000.00%
Signature Financial Management, Inc. 12,350$7,0000.00%
IHT Wealth Management, LLC 3,800$2,0000.00%
THOMPSON SIEGEL & WALMSLEY LLC 2,000$1,0000.00%
Smithfield Trust Co 2,052$1,0000.00%
VANGUARD GROUP INC 904,815$494,0000.00%
ROYAL BANK OF CANADA 1$00.00%
St. Johns Investment Management Company, LLC 23$00.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders